Abstract
Factor V Leiden (FVL) mutation is the most common thrombophilic marker associated with venous thromboembolism (VTE). The risk of VTE is increased 3- to 7-fold in heterozygotes and 50- to 100-fold in homozygotes of FVL mutation [1].
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
